COVID-19’s long-term impact on orphanhood and caregiver loss

United Kingdom News News

COVID-19’s long-term impact on orphanhood and caregiver loss
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 71%

COVID-19’s long-term impact on orphanhood and caregiver loss UniofOxford UCT_news imperialcollege COVID19 coronavirus covid orphan children

By Pooja Toshniwal PahariaSep 9 2022Reviewed by Danielle Ellis, B.Sc. In a recent study published in JAMA Pediatrics, researchers performed epidemiologic modeling to update coronavirus disease 2019 -associated caregiver and parent loss estimates.

Inter- and intra-country comparisons have been hampered previously due to inconsistent severe acute respiratory syndrome coronavirus 2 testing, associated mortality reporting, and access to new data of excess COVID-19-associated mortality enable updating minimum COVID-19 death estimates of caregiver and parent loss.

Bootstrapping was performed to calculate uncertainty for death estimates arising from mortality and fertility data. National and regional death estimates were calculated based on WHO-based methodology since the WHO findings showed higher conservatism than those of The Economist and IHME. The study was conducted in accordance with the GATHER guidelines.

Greater numbers of COVID-19-associated orphanhoods due to loss of primary and/or secondary caregivers were noted in Southeast Asia WHO regions and Africa , in comparison to the Eastern Mediterranean regions , American regions , Western Pacific regions and European regions by 1 May 2022.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Frontiers | T cell perturbations persist for at least 6 months following hospitalization for COVID-19Frontiers | T cell perturbations persist for at least 6 months following hospitalization for COVID-19COVID-19 is being extensively studied, and much remains unknown regarding the long-term consequences of the disease on immune cells. The different arms of the immune system are interlinked, with humoral responses and the production of high-affinity antibodies being largely dependent on T cell immunity. Here, we longitudinally explored the effect COVID-19 has on T cell populations and the virus-specific T cells, as well as neutralizing antibody responses, for 6-7 months following hospitalization. The CD8+ TEMRA and exhausted CD57+CD8+ T cells were markedly affected with elevated levels that lasted long into convalescence. Further, markers associated with T-cell activation were upregulated at the inclusion, and in the case of CD69+CD4+ T cells this lasted all through the study duration. The levels of T cells expressing negative immune checkpoint molecules were increased in COVID-19 patients and sustained for a prolonged duration following recovery. Within 2-3 weeks after symptom onset, all COVID-19 patients developed anti-nucleocapsid IgG and spike-neutralizing IgG as well as SARS-CoV-2-specific T cell responses. In addition, we found alterations in follicular T helper (TFH) cell populations, such as enhanced TFH-TH2 following recovery from COVID-19. Our study revealed significant and long-term alterations in T cell populations and key events associated with COVID-19 pathogenesis.
Read more »

Global Energy Employment Bounces Back Above Pre-Covid Levels | OilPrice.comGlobal Energy Employment Bounces Back Above Pre-Covid Levels | OilPrice.comGlobal energy employment has surpassed pre-pandemic levels due to hiring in the clean energy sectors, the International Energy Agency (IEA) said in its first-ever World Energy Employment Report on Thursday.
Read more »

Plants and plant-derived preparations as co-treatments for COVID-19Plants and plant-derived preparations as co-treatments for COVID-19Plants and plant-derived preparations as co-treatments for COVID-19 Coronavirus Disease COVID AntiInflammatory CD4 Chemokines Coronavirus Cytokines medicinalplants plantextracts therapeuticplants traditionalmedicine LiebertPub
Read more »

Study estimates prevalence of long-COVID with variant BA.5 in the U.S.Study estimates prevalence of long-COVID with variant BA.5 in the U.S.A new survey by City University of New York School of Public Health researchers and posted to the medRxiv * preprint server suggests the prevalence of severe acute respiratory syndrome coronavirus 2...
Read more »



Render Time: 2025-02-22 17:42:11